Indication
Giant Axonal Neuropathy
1 clinical trial
1 product
Clinical trial
A Phase I Study of Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal NeuropathyStatus: Active (not recruiting), Estimated PCD: 2030-06-30
Product
scAAv9/JeT-GAN